Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Diseases (AASK) Trial

Kidney International

Volumn 51, Issue 1, 1997, Pages 244-252

  Fogo, Agnes ^j   Breyer, Julia A ^a   Smith, Michael C ^k   Cleveland, William H ^a   Agodoa, Lawrence ^k   Kirk, Katharine A ^k   Glassock, Richard ^k   Faulkner, Marquette ^a   Hall, W Dallas ^b   Kopple, Joel D ^c   Massry, Shaul G ^d   Grim, Clarence ^e   Randall, Otalio S ^f   Toto, Robert D ^g   Whelton, Paul ^h   Wright Jr , Jackson T ⁱ  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e KING DREW MEDICAL CENTER   (United States)

^f HOWARD UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FIBROSIS; MALE; NEGRO; NEPHROSCLEROSIS; PRIORITY JOURNAL;

EID: 8044239657     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.29     Document Type: Article

References (64)

1. Hypertension in Blacks: Epidemiology, Pathophysiology, and Treatment. Edited by HALL WD, SAUNDERS E, SHULMAN NB, Chicago, Chicago Year Book Medical Publishers, 1985
2. NATIONAL HEALTH SURVEY: Hypertension and Hypertensive Heart Disease in Adults. U.S. 1960-62. Washington, D.C., U.S. Dept. of Health, Education and Welfare, Vital and Health Statistics Series 11, No. 13, U.S. Government Printing Office, 1966
3. LOPES AAS, PORT FK, JAMES SA, AGODOA L: The excess risk of treated end-stage renal disease in blacks in the United States. J Am Soc Nephrol 3:1961-1971, 1993
4. FELDMAN HI, KLAG MJ, CHIAPELLA AP, WHELTON PK: End-stage renal disease in US minority groups. Am J Kidney Dis 19:397-410, 1992
5. BLYTHE WB, MADDUX FW: Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. Am J Kidney Dis 18:33-37, 1991
6. U.S. RENAL DATA SYSTEM: USRDS 1995 Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, April 1995
7. DUSTAN HP, CURTIS JJ, LUKE RG, ROSTAND SG: Systemic hypertension and the kidney in black patients. Am J Cardiol 60:731-771, 1987
8. MESSERLI FH, GARAVAGLIA GE, SCHMIEDER RE, SUNDGAARD-RIISE K, NUNEZ BD, AMODEO C: Disparate cardiovascular findings in men and women with essential hypertension. Annals Int Med 107:158-161, 1987
9. HALL JE, GRANGER JP, SMITH MJ, PREMEN AJ: Role of renal hemodynamics and arterial pressure in aldosterone "escape". Hypertension 6:I183-I192, 1984
10. DUSTAN HP, VALUES G, BRAVO EL, TARAZI RC: Excessive sodium retention as a characteristic of salt-sensitive hypertension. Am J Med Sci 292:67-74, 1986
11. MESSERLI GH, DECARVALHO JGR, CHRISTIE B, FROHLICH ED: Essential hypertension in black and white subjects - Hemodynamic findings and fluid volume state. Am J Med 67:27-31, 1979
12. FROHLICH ED, MESSERLI FH, DUNN GF, OIGMAN W, VENTURE HO, SUNDGAARD-RIISE K: Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrol Metab 10:173-177, 1984
13. ENTWISLE G, APOSTOLIDES AY, HEBEL JR, HENDERSON MM: Target organ damage in black hypertensives. Circulation 55:792-796, 1977
14. KAPLAN NM: Hypertension in the population at large, in Clinical Hypertension (4th ed), edited by KAPLAN NM, Baltimore, Williams & Wilkins, 1986, pp 1-18
15. MCCLELLAN W, TUTTLE E, ISSA A: Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12:285-290, 1988
16. WHITTLE JC, WHELTON PK, SEIDLER AJ, KLAG MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151:1359-1364, 1991
17. SHULMAN NB, FORD CE, HALL WD, BLAUFOX MD, SIMON D, LANGFORD HG, SCHNEIDER KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(Suppl 5):180-193, 1989
18. HARVEY JM, HOWIE AJ, LEE SJ, NEWBOLD KM, ADU D, MICHAEL J, BEEVERS DG: Renal biopsy findings in hypertensive patients with proteinuria. Lancet 340:1435-1436, 1992
19. PERNEGER TV, WHELTON PK, KLAG MJ, ROSSITER KA: Diagnosis of hypertensive end-stage renal disease: Effect of patient's race. Am J Epidemiol 141:10-15, 1995
20. WRIGHT JT JR, KIRK KA, RANDALL OS, GLASSOCK R, AASK PILOT INVESTIGATORS: The design of the African-American Study of Kidney Disease and Hypertension (AASK). (abstract) J Am Soc Nephrol 5:570, 1994
21. WHELTON P, LEE J, KOPPLE J, FAULKNER M, CHARLESTON J FOR THE AASK PILOT INVESTIGATORS: Recruitment in the African-American Study of Kidney Disease and Hypertension (AASK) pilot study. (abstract) J Am Soc Nephrol 5:470, 1994
22. 125I-iothalamate. Kidney Int 4:346-349, 1973
23. KAPLAN C, PASTERNACK B, SHAH H, GALLO G: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80:227-234, 1975
24. KAPPEL B, OLSEN S: Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study. Virchows Arch (Pathol Anal) 387:271-277, 1980
25. SMITH SM, HOY WE, COBB L: Low incidence of glomerulosclerosis in normal kidneys. Arch Pathol Lab Med 113:1253-1256, 1989
26. NASH MA, GREIFER I, OLBING H, BERNSTEIN J, BENNETT B, SPITZER A: The significance of focal sclerotic lesions of glomeruli in children. J Pediatr 88:806-813, 1976
27. HEPTINSTALL RH: Hypertension I: Essential hypertension, in Pathology of the Kidney, edited by HEPTINSTALL RH, Boston, Little, Brown and Co, 1992, pp 962-971
28. STRIKER LJ, OLSON JL, STRIKER GE: Renal lesions in hypertension, in The Renal Biopsy. Major Problems in Pathology (vol. 8, 2 ed), edited by BENNINGTON JL, Philadelphia, WB Saunders Co, 1990, pp 241-253
29. KATZ SM, LAVIN L, SWARTZ C: Glomerular lesions in benign essential hypertension. Arch Pathol Lab Med 103:199-203, 1979
30. NARVARTE J, PRIVE M, SABA SR, RAMIREZ G: Proteinuria in hypertension. Am J Kidney Dis 10:408-416, 1987
31. MORDUCHOWICZ G, BONER G, BEN-BASSAT M, ROSENFELD JB: Proteinuria in benign nephrosclerosis. Arch Intern Med 146:1513-1516 1986
32. MORDUCHOWICZ G, BONER G, BEN-BASSAT B, ROSENFELD JB: Proteinuria in benign nephrosclerosis. Arch Intern Med 146:1513-1516, 1986
33. INNES A, JOHNSTON PA, MORGAN AG, DAVISON AM, BURDEN RP: Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Quart J Med 86:271-275, 1993
34. TRACY RE, GUZMAN MA, OALMANN MC, NEWMANN WP III, STRONG JP: Nephrosclerosis in three cohorts of black and white men born 1925 to 1944, 1934 to 1953, and 1943 to 1962. Am J Hypertens 6:185-192, 1993
35. U.S. VITAL HEALTH STATISTICS: Blood pressure levels in persons 18-74 years of age in 1976-80, and trends in blood pressure from 1960 to 1980 in the United States. National Health Survey Series 11(234):48-53, 1986
36. SOMMERS SC, RELMAN AS, SMITHWICK RH: Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 34:685-713, 1958
37. ZOLLINGER HU, MIHATSCH MJ: Renal changes caused by vascular disease, in Renal Pathology in Biopsy, edited by ZOLLINGER HU, MIHATSCH MJ, Berlin, Springer Verlag, 1978, pp 514-542
38. KINCAID-SMITH P, WHITWORTH JA: Hypertension and the Kidney, in The Kidney: A Clinicopathologic Study, Melbourne, Blackwell 1987 p 131
39. ROSTAND SG, BROWN G, KIRK K, RUTSKY EA, DUSTAN HP: Renal insufficiency in treated essential hypertension. N Engl J Med 320:684-688, 1989
40. WALKER GW, NEATON JD, CUTLER JA, NEUWIRTH R, COHEN JD: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 268:3085-3091, 1992
41. FREEDMAN BI, ISKANDAR SS, APPEL RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 25:207-221, 1995
42. FREEDMAN BI, ISKANDAR SS, BUCKALEW VM, BURKART JM, APPEL RG: Renal biopsy findings in presumed hypertensive nephrosclerosis. Am J Nephrol 14:90-94, 1994
43. TAMURA T: Histologic features of renal biopsies from patients with essential hypertension and from the aged. Jpn Circ J 30:829-862, 1966
44. KATAFUCHI R, TAKEBAYASHI S: Morphometrical and functional correlations in benign nephroselerosis. Clin Nephrol 28:238-243, 1987
45. HARVEY JM, HOWIE AJ, LEE SJ, NEWBOLD KM, ADU D, MICHAEL J, BEEVERS DG: Renal biopsy findings in hypertensive patients with proteinuria. Lancet 340:1435-1436, 1992
46. FREEDMAN BI, SPRAY BJ, TUTTLE AB, BUCKALEW VM JR: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21:387-393, 1993
47. FERGUSON R, GRIM CE, OPGENORTH TJ: A familial risk of chronic renal failure among blacks on dialysis. J Clin Epidemiol 41:1189-1196, 1988
48. TIEO KK: Angiotensin converting enzyme genotypes and disease. Brit Med J 311:76-77, 1995
49. BLOEM U, MANATUNGA AK, TEWKSBURY DA, PRATT JH: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95:948-953, 1995
50. RUTLEDGE DR, KUBILIS P, BROWL CS, ROSS EA: Polymorphism of the angiotensin 1 converting enzyme gene in essential hypertensive patients. Biochem Mol Biol Int 35:661-668, 1995
51. DURU K, FARROW S, WANG J-M, LOCKETTE W, KURTZ T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 7:759-762, 1994
52. HUNLEY TE, JULIAN BA, PHILLIPS JA, SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
53. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, KANAI T, MIYAZAKI Y, KAWAGUCHI Y, KUDO H, NAGASAWA R, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
54. JACOBSEN P, TARNOW L, ROSSING P, CAMBIEN F, LECERF L, POIRIER O, PARVING H-H: The insertion/deletion (1/D) polymorphism in the angiotensin-1-converting enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACEI) in insulin dependent diabetic (IDDM) patients. (abstract) J Am Soc Nephrol 6:450, 1995
55. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
56. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion geneotype (DD) for angiotensin-converting enzyme. Hypertension 25:1266-1269, 1995
57. PESCE C, SCHMIDT K, FOGO A, OKOYE MI, KIM R, STRIKER LJ, STRIKER GE: Glomerular size and the incidence of renal disease in African Americans and Caucasians. J Nephrol 7:355-358, 1994
58. BRENNER BM, CHERTOW GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994
59. HACK M, MERKATZ IR: Preterm delivery and low birth weight - A dire legacy. N Engl J Med 333:1772-1773, 1995
60. FOGO A, YOSHIDA Y, YARED A, ICHIKAWA I: Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38:1068-1074, 1990
61. TANAKA R, KON V, YOSHIOKA T, ICHIKAWA I, FOGO A: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537-543, 1994
62. ANDERSON S, RENNKE HG, ZATZ R: Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol 267:F35-F43, 1994
63. HEUDES D, MICHEL O, CHEVALIER J, SCALBERT E, EZAN E, BARIETY J, ZIMMERMAN A, CORMAN B: Effect of chronic Ang I-converting enzyme inhibition on aging processes: I. Kidney structure and function. Am J Physiol 266:R1038-R1051, 1994
64. MICHEL JB, HEUDES D, MICHEL O, POITEVIN P, PHILIPPE M, SCALBERT E, CORMAN B, LEVY BI: Effect of chronic Ang I-converting enzyme inhibition on aging processes: II. Large arteries. Am J Physiol 267: R124-R135, 1994